SK pharmteco to build $260M small molecule and peptide production facility in South Korea kdunleavy Mon, 09/30/2024 – 15:11 More: SK pharmteco to build 0M small molecule and peptide production facility in South Korea Source: fierce
read moreAfter landmark rare disease approval, IntraBio ready to ‘hit the ground running’ with Aqneursa launch fkansteiner Mon, 09/30/2024 – 12:57 More: After landmark rare disease approval, IntraBio ready to 'hit the ground running' with Aqneursa launch Source: fierce
read moreAstellas cruises into first DTC campaign for geographic atrophy treatment Izervay apark Mon, 09/30/2024 – 12:53 More: Astellas cruises into first DTC campaign for geographic atrophy treatment Izervay Source: fierce
read moreModerna rebuked over second successive Spikevax marketing breach ntaylor Mon, 09/30/2024 – 11:48 More: Moderna rebuked over second successive Spikevax marketing breach Source: fierce
read moreCDMOs eye industrywide growth in 2025 as many spurn BIOSECURE Act, CPHI research shows fkansteiner Mon, 09/30/2024 – 10:01 More: CDMOs eye industrywide growth in 2025 as many spurn BIOSECURE Act, CPHI research shows Source: fierce
read moreAfter Sanofi’s first-line myeloma nod, J&J strikes back with new tranche of Darzalex data fkansteiner Fri, 09/27/2024 – 15:04 More: After Sanofi's first-line myeloma nod, J&J strikes back with new tranche of Darzalex data Source: fierce
read more© 1994 - 2025 B.M. Pharmaceuticals